secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2025-08-08T23:59:59+00:00
Accession:  0001493152-25-011775
Event type: regulatory
Sentiment:  negative
Materiality: 0.40
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa receives second 180-day grace period to regain Nasdaq bid price compliance
--------------------------------------------------------------------------------

- Grace period runs until February 2, 2026 to meet $1.00 minimum bid price.
- Compliance requires closing bid price ≥ $1.00 for 10 consecutive business days.
- Company will consider a reverse stock split if needed to cure deficiency.
- Common stock continues trading on Nasdaq Capital Market during the period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315225011775/0001493152-25-011775-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315225011775/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-011775

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer